Semler Scientific (NASDAQ:SMLR) Hits New 52-Week High – Here’s Why

Semler Scientific, Inc. (NASDAQ:SMLR) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $80.74 and last traded at $77.00, with a volume of 259005 shares changing hands. The stock had previously closed at $74.50.

Semler Scientific Trading Up 6.5 %

The business has a 50 day moving average of $44.80 and a 200-day moving average of $35.13. The stock has a market cap of $657.73 million, a PE ratio of 38.71 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million for the quarter.

Institutional Investors Weigh In On Semler Scientific

Several hedge funds have recently made changes to their positions in SMLR. CWM LLC raised its stake in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new position in Semler Scientific in the 2nd quarter valued at $34,000. Quest Partners LLC acquired a new position in Semler Scientific in the 2nd quarter valued at $59,000. Meeder Asset Management Inc. purchased a new position in Semler Scientific during the 2nd quarter worth $67,000. Finally, US Bancorp DE boosted its holdings in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after acquiring an additional 1,158 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.